| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 159.391 | 31.991 | 199.290 | 155.525 | 155.507 | 152.446 | 153.047 | 193.094 | 194.319 | 225.843 |
| Total Income - EUR | 159.434 | 32.015 | 202.111 | 160.259 | 168.814 | 160.019 | 165.208 | 200.089 | 196.341 | 227.436 |
| Total Expenses - EUR | 138.413 | 31.743 | 186.863 | 129.995 | 144.853 | 134.108 | 134.907 | 173.962 | 178.032 | 191.862 |
| Gross Profit/Loss - EUR | 21.020 | 272 | 15.247 | 30.264 | 23.961 | 25.911 | 30.301 | 26.128 | 18.310 | 35.574 |
| Net Profit/Loss - EUR | 17.525 | 180 | 11.444 | 28.673 | 22.398 | 24.380 | 29.109 | 24.264 | 16.797 | 29.618 |
| Employees | 17 | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Biodravin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.845 | 13.951 | 17.398 | 17.596 | 16.665 | 15.291 | 15.971 | 15.430 | 11.560 | 11.321 |
| Current Assets | 66.857 | 103.374 | 113.024 | 47.629 | 88.730 | 100.341 | 130.962 | 46.465 | 59.827 | 71.241 |
| Inventories | 0 | 296 | 15.568 | 12.410 | 15.328 | 21.964 | 28.663 | 26.722 | 26.780 | 48.951 |
| Receivables | 72.951 | 102.113 | 95.525 | 33.105 | 72.489 | 76.372 | 101.890 | 18.457 | 31.185 | 17.300 |
| Cash | -6.094 | 965 | 1.931 | 2.114 | 913 | 2.005 | 409 | 1.286 | 1.861 | 4.990 |
| Shareholders Funds | 76.930 | 76.326 | 86.479 | 32.009 | 53.788 | 77.148 | 104.546 | 27.745 | 43.465 | 49.119 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 3.771 | 40.999 | 43.944 | 33.215 | 51.607 | 38.485 | 42.386 | 34.150 | 27.921 | 33.443 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "210 - 210" | |||||||||
| CAEN Financial Year |
210
|
|||||||||
Comments - Biodravin Srl